| Literature DB >> 35866892 |
Hanjia Zheng1, Amin GhavamiNejad2, Peyman GhavamiNejad1, Melisa Samarikhalaj3, Adria Giacca3, Mahla Poudineh1.
Abstract
Analyzing interstitial fluid (ISF) via microneedle (MN) devices enables patient health monitoring in a minimally invasive manner and in point-of-care settings. However, most MN-based diagnostic approaches require complicated fabrication processes and postprocessing of the extracted ISF or are limited to detection of electrochemically active biomarkers. Here, we show on-needle measurement of target analytes by integrating hydrogel microneedles with aptamer probes as the recognition elements. Fluorescently tagged aptamer probes are chemically attached to the hydrogel matrix using a simple and novel approach, while a cross-linked patch is formed. For reagentless detection, we employ a strand displacement strategy where fluorophore-conjugated aptamers are hybridized with a DNA competitor strand conjugated to a quencher molecule. The assay is utilized for rapid (2 min) measurement of glucose, adenosine triphosphate, l-tyrosinamide, and thrombin ex vivo. Furthermore, the system enables specific and sensitive quantification of rising and falling concentrations of glucose in an animal model of diabetes to track hypoglycemia, euglycemia, and hyperglycemia conditions. Our assay can be applied for rapid measurement of a diverse range of biomarkers, proteins, or small molecules, introducing a generalizable platform for biomolecule quantification, and has the potential to improve the quality of life of patients who are in need of close monitoring of biomarkers of health and disease.Entities:
Keywords: aptamer probes; generalizable assay; hydrogel microneedles; methacrylated hyaluronic acid; on-needle detection; transdermal biomolecule sensing
Mesh:
Substances:
Year: 2022 PMID: 35866892 DOI: 10.1021/acssensors.2c01033
Source DB: PubMed Journal: ACS Sens ISSN: 2379-3694 Impact factor: 9.618